Mesoblast Limited (FRA:LWB)

Mesoblast Statistics

Total Valuation

Mesoblast has a market cap or net worth of EUR 1.93 billion. The enterprise value is 1.90 billion.

Market Cap	1.93B
Enterprise Value	1.90B

Important Dates

The last earnings date was Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	+22.41%
Shares Change (QoQ)	+11.47%
Owned by Insiders (%)	32.81%
Owned by Institutions (%)	25.52%
Float	851.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	131.82
PB Ratio	3.79
P/TBV Ratio	88.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-21.87
EV / Sales	128.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-44.11

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.21.

Current Ratio	1.99
Quick Ratio	1.72
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	-2.53
Interest Coverage	-2.87

Financial Efficiency

Return on equity (ROE) is -18.95% and return on invested capital (ROIC) is -5.89%.

Return on Equity (ROE)	-18.95%
Return on Assets (ROA)	-5.37%
Return on Invested Capital (ROIC)	-5.89%
Return on Capital Employed (ROCE)	-9.16%
Revenue Per Employee	180,791
Profits Per Employee	-1.07M
Employee Count	81
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, Mesoblast has paid 280,995 in taxes.

Income Tax	280,995
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+45.55%
50-Day Moving Average	1.37
200-Day Moving Average	1.15
Relative Strength Index (RSI)	62.22
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mesoblast had revenue of EUR 14.64 million and -86.97 million in losses. Loss per share was -0.07.

Revenue	14.64M
Gross Profit	-19.36M
Operating Income	-53.17M
Pretax Income	-86.69M
Net Income	-86.97M
EBITDA	-49.54M
EBIT	-53.17M
Loss Per Share	-0.07

Balance Sheet

The company has 137.56 million in cash and 109.13 million in debt, giving a net cash position of 28.43 million.

Cash & Cash Equivalents	137.56M
Total Debt	109.13M
Net Cash	28.43M
Net Cash Per Share	n/a
Equity (Book Value)	508.72M
Book Value Per Share	0.40
Working Capital	86.62M

Cash Flow

In the last 12 months, operating cash flow was -42.54 million and capital expenditures -579,020, giving a free cash flow of -43.11 million.

Operating Cash Flow	-42.54M
Capital Expenditures	-579,020
Free Cash Flow	-43.11M
FCF Per Share	n/a

Margins

Gross Margin	-132.22%
Operating Margin	-363.08%
Pretax Margin	-592.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mesoblast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.41%
Shareholder Yield	-22.41%
Earnings Yield	-4.51%
FCF Yield	-2.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mesoblast has an Altman Z-Score of 2.45 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.45
Piotroski F-Score	5